Protein Binding of Phenytoin, p‐Hydroxy Phenytoin, and p‐Hydroxy Phenytoin Glucuronide
- 12 November 1986
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 26 (8) , 677-679
- https://doi.org/10.1002/j.1552-4604.1986.tb02971.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Protein Binding of Disopyramide and Elevated Alpha-1-Acid Glycoprotein Concentrations in Serum Obtained from Dialysis Patients and Renal Transplant RecipientsAmerican Journal of Nephrology, 1985
- Contribution of 5-(4-Hydroxyphenyl)-5-phenylhydantoin to the Discrepancy Between Phenytoin Analyses by EMIT and High-Pressure Liquid ChromatographyTherapeutic Drug Monitoring, 1984
- Use of Antiepileptic Drugs in the Presence of Liver and Kidney Diseases: A ReviewEpilepsia, 1982
- Metabolite interference in homogeneous enzyme immunoassay of phenytoin.Clinical Chemistry, 1981
- Plasma levels and renal excretion of phenytoin and its metabolites in patients with renal failureClinical Pharmacology & Therapeutics, 1979
- Plasma concentrations of 5‐(4‐hydroxyphenyl)‐5‐phenylhydantoin in phenytoin‐treated patientsClinical Pharmacology & Therapeutics, 1977
- Kinetics of diphenylhydantoin in uraemic patients: Consequences of decreased plasma protein bindingEuropean Journal of Clinical Pharmacology, 1974
- The renal handling of diphenylhydantoin and 5‐(p‐hydroxyphenyl)‐5‐phenylhydantoinClinical Pharmacology & Therapeutics, 1973
- Diphenylhydantoin Metabolism in UremiaNew England Journal of Medicine, 1971